Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Selic Pharmaceutical is a Chinese pharmaceutical company headquartered in Haikou, specializing in the development and production of high-quality generic drugs. The company maintains a strong focus on oncology, anti-infectives, and cardiovascular health, providing essential medications to the Chinese healthcare market. Operating from GMP-certified facilities, Hainan Selic produces a variety of formulations, including lyophilized powder for injection and oral tablets. Their portfolio features prominent oncology treatments such as imatinib and gefitinib, which have undergone rigorous consistency evaluations. The company is committed to enhancing patient access to affordable medicine through efficient manufacturing and strategic distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Selic Pharmaceutical.